<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Drugs used in chronic conditions 1 | Essentials of Pharmacology for Nurses</title>
    
    <!-- Preconnect for performance -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    
    <!-- Google Fonts - Inter for UI, Source Serif for reading -->
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <!-- Main Stylesheet -->
    <link rel="stylesheet" href="../styles/main.css">
    
    <!-- MathJax Configuration -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams'
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <!-- Skip Link for Accessibility -->
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <!-- Reading Progress Bar -->
    <div class="reading-progress-container" aria-hidden="true">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <!-- Theme Toggle (Fixed Position) -->
    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode" title="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <div class="page-wrapper">
        <!-- Floating Mini-TOC -->
        <aside class="floating-toc" id="floating-toc" aria-label="On this page">
            <div class="floating-toc-header">
                <span class="floating-toc-icon">üìë</span>
                <span>On this page</span>
            </div>
            <nav class="floating-toc-nav">
                <ul class="floating-toc-list">
                    <!-- Populated by JS -->
                </ul>
            </nav>
        </aside>

        <div class="container">
            <article class="document-article" role="main" id="main-content">
                <!-- Top Navigation -->
                <nav class="document-nav" role="navigation" aria-label="Document navigation">
                    <div class="nav-container">
                        <a href="../index.html" class="nav-button nav-button--toc" aria-label="Table of Contents">
                            <span class="nav-icon">üìö</span>
                            <span class="nav-text">Contents</span>
                        </a>
                        
                        <a href="topic-07-anticoagulant.html" class="nav-button nav-button--prev" aria-label="Previous section">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Previous</span>
                        </a>
                        
                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span class="progress-current">8</span>
                                <span class="progress-separator">/</span>
                                <span class="progress-total">13</span>
                            </div>
                            <div class="progress-bar-container" aria-hidden="true">
                                <div class="progress-bar-fill" style="width: 61%;"></div>
                            </div>
                            <span class="progress-label">Drugs used in chronic conditions 1</span>
                        </div>
                        
                        <a href="topic-09-chronic-2.html" class="nav-button nav-button--next" aria-label="Next section">
                            <span class="nav-text">Next</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                </nav>

                <!-- Breadcrumb -->
                <nav class="breadcrumb" aria-label="Breadcrumb">
                    <ol class="breadcrumb-list">
                        <li class="breadcrumb-item"><a href="../index.html">Home</a></li>
                        <li class="breadcrumb-item"><a href="../index.html">Topics</a></li>
                        <li class="breadcrumb-item active" aria-current="page">Chronic Conditions 1</li>
                    </ol>
                </nav>

                <!-- Document Header -->
                <header class="document-header">
                    <div class="header-badge">
                        <span class="badge-icon">üìñ</span>
                        <span class="badge-text">Chapter 8</span>
                    </div>
                    <h1 class="document-title">Drugs used in chronic conditions 1</h1>
                    <p class="hero-subtitle">Respiratory conditions: Asthma and COPD</p>
                    <div class="title-meta">
                        <span class="meta-item">
                            <span class="meta-icon">üìÑ</span>
                            <span>Chronic Disease Management</span>
                        </span>
                        <span class="meta-item">
                            <span class="meta-icon">‚è±Ô∏è</span>
                            <span>30 min read</span>
                        </span>
                    </div>
                </header>

                <!-- Main Content Area -->
                <div class="content-wrapper">
                    
                    <!-- Learning Objectives -->
                    <aside class="callout callout--note" role="note">
                        <div class="callout-header">
                            <span class="callout-icon">üéØ</span>
                            <span class="callout-title">Learning Objectives</span>
                        </div>
                        <div class="callout-content">
                            <p>After studying this chapter you should be able to:</p>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Describe the basic pathology involved in asthma and COPD.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Explain the mode of action of medicines used in treating these conditions.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Demonstrate an understanding of the unwanted effects of medicines used in treating these conditions.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Discuss the correct technique involved when teaching a person to use an inhaler.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Demonstrate an understanding of the links between the pharmacology of therapies used in treating respiratory conditions and the care given by the health practitioner.</span></li>
                            </ul>
                        </div>
                    </aside>

                    <!-- START: Introduction -->
                    <section id="introduction" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">01</div>
                            <h2 class="section-title">Introduction</h2>
                        </div>
                        
                        <div class="content-card">
                            <p>Many chronic diseases are brought about by demographic, environmental and lifestyle changes and the chronic conditions of the respiratory system are a good example of this. This chapter will look at asthma and COPD, as these form the majority of the diagnoses of respiratory conditions.</p>
                        </div>
                    </section>

                    <!-- START: Asthma -->
                    <section id="asthma" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">02</div>
                            <h2 class="section-title">Asthma</h2>
                        </div>
                        
                        <div class="content-card">
                            <p>Asthma is the leading chronic disease in developed countries and its incidence is increasing. The condition is brought on by a reversible obstruction of the airways which in turn causes the individual to become breathless and start to cough or wheeze. Asthma may be described as being acute or chronic. Severe acute asthma (known as status asthmaticus) is not reversed very easily and, as a result, continues to be fatal and requires prompt treatment. Chronic asthma usually has an intermittent pattern of breathlessness (dyspnoea), coughing and wheezing.</p>
                            <p>In acute asthma the main reason for obstruction of the airways is bronchoconstriction caused by a substance called histamine. Further significant obstruction of the airways is brought about by inflammatory changes in the mucosa which cause an increase in mucous production, more epithelial cells being shed and swelling of the tissues within the respiratory passages.</p>
                            <p>Asthma symptoms are thought to be caused by what doctors describe as hyper-reactivity or hyper-responsiveness of the cells lining the air passages. It seems that bronchiolar tissue in certain individuals is more sensitive to certain trigger factors than other people in the general population. Trigger factors include irritant chemicals, exposure to foreign proteins called allergens, and cold air.</p>
                            
                            <h3>Pathological changes in asthma</h3>
                            <p>The changes in the respiratory system that bring about asthma are initiated by an allergic reaction.</p>
                            <p>The trigger factor stimulates the body's immune response and as part of this the body produces a type of white cell called a B-lymphocyte. Some of these B-lymphocytes mature into a type of cell called a plasma cell. These cells produce a chemical called immunoglobulin E which is a type of antibody. These antibodies in turn attach themselves to a type of tissue cell called a mast cell.</p>
                            <p>These mast cells are now stimulated to produce a substance called histamine. Histamine is a potent constrictor of the muscles in the air passages, causing them to become narrowed. This is called bronchoconstriction. Histamine also causes local blood vessels to dilate and become more permeable so that other inflammatory cells in the plasma can move into the tissues. Not only does histamine cause constriction of bronchial smooth muscle, it also leads to swelling of the tissues.</p>
                            <p>Another specific group of white cells thought to be involved in asthma are the eosinophils. This group of cells are implicated in the inflammatory response by releasing a range of chemicals that contribute to the contraction of bronchial smooth muscle, permeability of small blood vessels and excessive secretion of mucous. It is also suggested that the eosinophils produce chemicals that have a toxic effect on the epithelial lining of the airways and are responsible for the greater amount of epithelial shedding associated with this condition.</p>
                            
                            <h3>Asthma in children</h3>
                            <p>Asthma is the leading cause of chronic illness in children. It affects as many as 15 per cent of children in the UK and, for unknown reasons, is steadily increasing. It can begin at any age, but most children have their first symptoms by age 5. Children still die from asthma - there were 27 recorded deaths in 2005 - and there is still significant disability associated with the disease, particularly severe childhood asthma, despite pharmacological advances.</p>
                            
                            <aside class="callout callout--tip" role="note">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ú®</span>
                                    <span class="callout-title">Clinical tip</span>
                                </div>
                                <div class="callout-content">
                                    <p>You will probably be asked to give a child asthma medications using a nebulizer while on placement. A nebulizer delivers asthma drugs, usually bronchodilators, by changing them from a liquid to a mist. The child gets the drug by breathing it in through a facemask. These breathing treatments usually take about 10-15 minutes and are given several times a day. Children may be able to use a metered dose inhaler (MDI) with a spacer. A spacer is a chamber that attaches to the MDI and holds the burst of medication (see Figure 8.1).</p>
                                </div>
                            </aside>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251210-7a3d6aeb.jpeg" alt="Examples of spacers" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Figure 8.1 Examples of spacers</figcaption>
                            </figure>
                        </div>
                    </section>
                    <!-- END: Asthma -->

                    <!-- START: Drugs for Asthma -->
                    <section id="asthma-drugs" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">03</div>
                            <h2 class="section-title">Drugs used in treating asthma</h2>
                        </div>
                        
                        <div class="content-card">
                            <p>There are two basic drug groups given to patients who have asthma: bronchodilators and antiinflammatory agents (see Box 8.1). They are not mutually exclusive - i.e. some bronchodilators may have an effect on inflammatory cells. Bronchodilators are the first group of drugs that we will focus upon.</p>
                            
                            <!-- Box 8.1 Table -->
                            <div class="table-wrapper">
                                <div class="table-header">
                                    <span class="table-icon">üìä</span>
                                    <span class="table-caption">Box 8.1 Management of asthma for children over 5 into adulthood</span>
                                </div>
                                <div class="table-container">
                                    <table class="content-table">
                                        <thead>
                                            <tr>
                                                <th>Steps</th>
                                                <th>Child key</th>
                                                <th>Adult key</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td>1 - Mild intermittent asthma</td>
                                                <td>Inhaled short-acting beta 2 agonist as required</td>
                                                <td>Inhaled short-acting beta 2 agonist as required</td>
                                            </tr>
                                            <tr>
                                                <td>2 - Regular preventer therapy</td>
                                                <td>Add inhaled steroid $200-400\mathrm{mcg}$ per day</td>
                                                <td>Add inhaled steroid $200-800\mathrm{mcg}$ per day</td>
                                            </tr>
                                            <tr>
                                                <td>3 - Initial add-on therapy</td>
                                                <td>Add inhaled long-acting beta 2 agonist<br>Assess the control of the asthma</td>
                                                <td>Add inhaled long-acting beta 2 agonist<br>Assess the control of the asthma</td>
                                            </tr>
                                            <tr>
                                                <td>4 - Persistent poor control</td>
                                                <td>Increase the inhaled steroid up to 800mcg per day</td>
                                                <td>Consider trials of increasing inhaled steroid up to 2000mcg per day. Add a fourth drug (e.g. slow release theophylline)</td>
                                            </tr>
                                            <tr>
                                                <td>5 - Continuous or frequent use of steroids</td>
                                                <td>Use daily steroid tablet</td>
                                                <td>Use daily steroid tablet</td>
                                            </tr>
                                            <tr>
                                                <td colspan="3">Based on the British Thoracic Society Guidelines 2008</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>

                            <h3>Beta 2 adrenoreceptor agonists</h3>
                            <p>These drugs are referred to as bronchodilators. They open the air passages by directly activating beta receptors, relaxing the smooth muscle in the walls of the bronchioles. This allows a more normal movement of air between the atmosphere and the alveoli. This group of drugs is available in both short- and long-acting forms. An example of a short-acting form in this class is salbutamol.</p>
                            
                            <aside class="callout callout--note" role="note">
                                <div class="callout-header">
                                    <span class="callout-icon">üí°</span>
                                    <span class="callout-title">Clinical tip</span>
                                </div>
                                <div class="callout-content">
                                    <p>Beta 2 adrenoreceptor agonists are often referred to as 'rescue remedies' because they ease the difficult breathing (dyspnoea), shortness of breath and wheezing associated with an asthma attack. Generally, these drugs have a short period of action.</p>
                                </div>
                            </aside>

                            <p>Most short-acting beta 2 agonists are available as aerosols to inhale by mouth several times a day. Most are also available as solutions that can be used with a special apparatus called a nebulizer. The maximum effect occurs within 30 minutes and the duration of action is between four and six hours. The patient is usually prescribed the drug on a 'prn' (pro re nata - as required) basis.</p>

                            <aside class="callout callout--note" role="note">
                                <div class="callout-header">
                                    <span class="callout-icon">üí°</span>
                                    <span class="callout-title">Clinical tip</span>
                                </div>
                                <div class="callout-content">
                                    <p>The longer-acting drugs in this class are often called 'controllers' because they help people with moderate to severe asthma control their symptoms. The effects of these drugs are longer-lasting at around 12 hours. An example of a drug in this class is salmeterol.</p>
                                </div>
                            </aside>

                            <h3>Methylxanthines</h3>
                            <p>The drug from this family most commonly employed in the clinical setting is theophylline, which works as a bronchodilator by relaxing the bronchial smooth muscle. Several mechanisms of action have been proposed but it is still unclear how this drug produces its effects. Recently theophylline has also been shown to have some antiinflammatory activity, especially with regard to mast cell activity. Theophylline is a useful drug in that it produces bronchial dilation so reducing the symptoms of chronic asthma, reducing the dosage of oral corticosteroids and reducing the requirement for symptomatic use of beta 2 adrenoreceptor agonists.</p>
                            <p>Deaths associated with theophylline have been reported and are due to the serious cardiovascular side-effect of dysrhythmia. Seizures are also a further life-threatening side-effect and can occur in concentrations only just above the therapeutic level.</p>

                            <h3>Muscarinic receptor antagonists</h3>
                            <p>The parasympathetic nervous system causes bronchoconstriction; therefore, if these effects on the bronchioles of the lungs were blocked dilatation would take place. This is the basic premise of this group of drugs. The compounds are used mainly in asthma, chronic bronchitis and COPD.</p>
                            
                            <h4>Ipratropium</h4>
                            <p>This medicine comes as a solution to inhale by mouth, either as an aerosol or in a nebulizer. The aerosol is usually prescribed four times a day. The bronchodilator effect begins after approximately 45 minutes and lasts for about three to five hours. This drug can cause side-effects ranging from leaving an unpleasant taste in the mouth and/or a dry mouth to rashes, hoarseness and chest pain.</p>

                            <h3>Inhaled corticosteroids</h3>
                            <p>Glucocorticoids are dealt with in more detail in Chapter 6. They do not bring about bronchodilatation and are not given as an immediate response to the trigger factor. However, inhaled corticosteroids are now a regular therapy in asthma management. Two drugs commonly used are beclometasone dipropionate and budesonide. Both have anti-inflammatory and immunosuppressive activity. When inhaled they prevent the production of a chemical called arachidonic acid which in turn leads to the reduced formation of prostaglandins and leucotrienes, reducing the inflammatory response (see Chapter 6). Both drugs when taken regularly reduce the frequency of 'rescue' bronchodilator intake.</p>
                            
                            <aside class="callout callout--warning" role="alert">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ö†Ô∏è</span>
                                    <span class="callout-title">Clinical tip</span>
                                </div>
                                <div class="callout-content">
                                    <p>Candidiasis can be prevented to some extent by rinsing the mouth after inhaling the drug or using a special device called a spacer which reduces the deposits of the drug in the tissues of the mouth and throat. The patient may have to be treated with antifungal lozenges.</p>
                                </div>
                            </aside>

                            <h3>Cromoglicate</h3>
                            <p>This medicine is not a bronchodilator, however if given prior to an asthmatic attack it prevents the immediate and later bronchoconstrictive reactions to inhaled allergens by stopping the release of mediators such as histamine from mast cells. It is thought that this medicine blocks calcium channels from opening in the mast cells. As calcium is blocked from entering the cells, so in turn is the release of inflammatory mediators. However, its exact mode of action is still not known.</p>
                        </div>
                    </section>
                    <!-- END: Drugs for Asthma -->

                    <!-- START: Inhaler Technique -->
                    <section id="inhaler-technique" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">04</div>
                            <h2 class="section-title">Inhaler technique</h2>
                        </div>
                        
                        <div class="content-card">
                            <p>As inhaled medicines are so important in the management of asthma it is equally important that nurses educate their patients in a systematic manner (Figure 8.2).</p>
                            
                            <ol class="enhanced-list">
                                <li class="list-item"><span class="list-marker">1</span><span class="list-content">Get the patient to hold the inhaler with the clear end pointing upwards. Place the metal canister inside the clear end, ensuring that it is fully and firmly in place and that the canister is at room temperature.</span></li>
                                <li class="list-item"><span class="list-marker">2</span><span class="list-content">Remove the protective dust cap from the end of the mouthpiece. If the cap was not placed on the mouthpiece, check the mouthpiece for dirt or other objects.</span></li>
                                <li class="list-item"><span class="list-marker">3</span><span class="list-content">If the patient is using the inhaler for the first time or has not used it in the last three days, get them to prime it by pressing down on the canister to release two sprays into the air, away from their face. Ensure they do not spray the medication into their eyes.</span></li>
                                <li class="list-item"><span class="list-marker">4</span><span class="list-content">Ask the patient to breathe out as completely as possible through their mouth, then to hold the inhaler between the thumb and the next two fingers with the mouthpiece at the bottom and facing them. The patient should then place the open end of the mouthpiece into their mouth and avoid covering the drug outlet piece with their tongue. The patient should close their lips tightly around the mouthpiece and close their eyes.</span></li>
                                <li class="list-item"><span class="list-marker">5</span><span class="list-content">The patient should now breathe in slowly and deeply through the mouthpiece at the same time pressing down firmly on the top of the canister.</span></li>
                                <li class="list-item"><span class="list-marker">6</span><span class="list-content">The patient should hold their breath for a count of 10, then remove the inhaler and breathe out slowly.</span></li>
                                <li class="list-item"><span class="list-marker">7</span><span class="list-content">If the patient is to take another dose, ask them to wait for approximately 15 seconds and then repeat steps 4-6.</span></li>
                                <li class="list-item"><span class="list-marker">8</span><span class="list-content">Finally ask the patient to replace the protective cap on the inhaler.</span></li>
                            </ol>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <div style="display: flex; flex-direction: column; gap: 1rem;">
                                        <img src="../assets/images/image-20251210-4f75a4b0.jpeg" alt="Shake the medicine" class="figure-image">
                                        <img src="../assets/images/image-20251210-092d9009.jpeg" alt="Breathe in slowly while pressing canister" class="figure-image">
                                        <img src="../assets/images/image-20251210-0bf6b3f4.jpeg" alt="Hold breath" class="figure-image">
                                    </div>
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Figure 8.2 Inhaler technique</figcaption>
                            </figure>
                        </div>
                    </section>
                    <!-- END: Inhaler Technique -->

                    <!-- START: COPD -->
                    <section id="copd" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">05</div>
                            <h2 class="section-title">Chronic obstructive pulmonary disease</h2>
                        </div>
                        
                        <div class="content-card">
                            <p>COPD is a general term which includes the conditions chronic bronchitis and emphysema. COPD is the preferred term, but you may also hear it called 'chronic obstructive airways disease' (COAD). Chronic bronchitis and emphysema commonly occur alongside each other, leading to the airways becoming narrowed and a limitation of the flow of air to and from the lungs, causing shortness of breath. In clinical practice, COPD is defined by its characteristically low airflow in lung function tests. In contrast to asthma, this limitation is poorly reversible and usually gets progressively worse over time. In England, approximately 1 person in 59 is diagnosed with COPD at some point in their lives.</p>
                            <p>The most common cause of COPD is smoking. Once you give up smoking, you gradually reduce the chances of suffering from COPD, and you slow down its progress if you already have it.</p>
                            
                            <h3>Drugs used in treating COPD</h3>
                            <p>Doctors use several kinds of medications to treat the symptoms and complications of COPD. A patient may take some medications on a regular basis and others as needed. Many of these medicines have been covered under the section on asthma such as beta 2 adrenoreceptor agonists, methylxanthines, muscarinic receptor antagonists and inhaled corticosteroids. However there are other drugs that you will come across when nursing someone with COPD that you will need to know about.</p>

                            <h4>Inhaled long-acting beta 2 agonists (LABAs)</h4>
                            <p>Examples of medicines in this category that you are likely to come across are formoterol and salmeterol. They improve the function of the lungs, the patient will also state that they feel breathing is easier for them and they feel generally less breathlessness. Formoterol and salmeterol have 12-hour durations of action; this compares to 4-6 hours in salbutamol.</p>
                            <p>Indacaterol is a new LABA that is being developed with the characteristics that we have just outlined. Indacaterol has a 24-hour duration of bronchodilation and rapid onset of action.</p>

                            <h4>Long-acting muscarinic antagonists (LAMAs)</h4>
                            <p>It is not only LABAs that have increased the quality of life for patients with COPD but also the advent of long-acting anti-muscarinic drugs such as tiotropium, aclidinium and glycopyrronium.</p>
                            <p>Tiotropium is probably the drug you are most familiar with. This was the first to be formulated in this classification of drugs. It has been shown by many studies to be an effective bronchodilator which has a long-lasting effect on the tissues. Tiotropium provides consistent 24-hour bronchodilation.</p>
                            
                            <div class="content-figure" data-lightbox="true" style="display: flex; gap: 2rem; justify-content: center; flex-wrap: wrap;">
                                <figure>
                                    <div class="figure-image-wrapper">
                                        <img src="../assets/images/image-20251210-f6c49d17.jpeg" alt="A handihaler" class="figure-image">
                                    </div>
                                    <figcaption class="figure-caption">Figure 8.3 A handihaler</figcaption>
                                </figure>
                                <figure>
                                    <div class="figure-image-wrapper">
                                        <img src="../assets/images/image-20251210-092ee93c.jpeg" alt="An aclidinium device" class="figure-image">
                                    </div>
                                    <figcaption class="figure-caption">Figure 8.4 An aclidinium device</figcaption>
                                </figure>
                                <figure>
                                    <div class="figure-image-wrapper">
                                        <img src="../assets/images/image-20251210-f75907eb.jpeg" alt="A glycopyrronium inhaler device" class="figure-image">
                                    </div>
                                    <figcaption class="figure-caption">Figure 8.5 A glycopyrronium inhaler device</figcaption>
                                </figure>
                            </div>

                            <h4>Phosphodiesterase 4 inhibitors</h4>
                            <p>If we could pharmacologically inhibit the inflammatory response in this disease then we would improve the symptoms for the patient and his quality of life. This is what the phosphodiesterase 4 inhibitors do. They are a relatively new addition to the treatment of COPD and their mode of action is anti-inflammatory in nature. Examples of drugs in this class are cilomilast and roflumilast - described as potent and selective phosphodiesterase (PDE) 4 inhibitors.</p>
                        </div>
                    </section>
                    <!-- END: COPD -->

                    <!-- START: Case Studies -->
                    <section id="case-studies" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">06</div>
                            <h2 class="section-title">Case studies</h2>
                        </div>
                        
                        <div class="content-card">
                            <h4>Case Study 1: Joseph Olita</h4>
                            <p>Joseph Olita, a 30-year-old man, has been on salbutamol inhaler and inhaled steroids for many years. His asthma has never really been under control and the requirement of steroid and beta-agonist usage has increased steadily. It is suspected that Joseph has not been using his inhalers properly. You are asked to reinforce this patient's technique. What steps would you take the patient through and what advice would you give?</p>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Discuss with reference to the mode of action of the two medicines.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Discuss with reference to the correct inhaler technique.</span></li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h4>Case Study 2: Elizabeth Jones</h4>
                            <p>Elizabeth Jones is 11 years old and is asthmatic. Her asthma is well controlled on the following medication: a salbutamol 'easibreath' device, two puffs as required for breathlessness; an inhaled corticosteroid prophylaxis. Elizabeth is moving up to high school and is embarrassed about using her inhalers in front of her classmates. Explain to her the benefits of preventative use of her steroid inhaler and the necessity of using her salbutamol to prevent severe asthma attack.</p>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Discuss with reference to corticosteroid action on the airways and bronchodilation produced by salbutamol.</span></li>
                            </ul>
                        </div>
                    </section>
                    <!-- END: Case Studies -->

                    <!-- Key Points Section -->
                    <aside class="key-points-section" role="region" aria-labelledby="key-points-title">
                        <div class="key-points-wrapper">
                            <div class="key-points-header">
                                <span class="key-points-icon">‚≠ê</span>
                                <h3 id="key-points-title" class="key-points-title">Key Learning Points</h3>
                            </div>
                            <ul class="key-points-list">
                                <li class="key-point-item"><span class="point-marker">‚úì</span><p><strong>Asthma can be described as acute and chronic and is triggered by chemicals, foreign proteins and cold air.</strong></p></li>
                                <li class="key-point-item"><span class="point-marker">‚úì</span><p><strong>Respiratory changes are triggered by an allergic response where histamine is released causing bronchoconstriction.</strong></p></li>
                                <li class="key-point-item"><span class="point-marker">‚úì</span><p><strong>Asthma affects as many as 15 per cent of children in the UK.</strong></p></li>
                                <li class="key-point-item"><span class="point-marker">‚úì</span><p><strong>Two groups of drugs are used in treating asthma: bronchodilators and inhaled anti-inflammatories.</strong></p></li>
                                <li class="key-point-item"><span class="point-marker">‚úì</span><p><strong>Examples of bronchodilators are salbutamol and theophylline. Examples of inhaled corticosteroids are beclomethasone and budesonide.</strong></p></li>
                                <li class="key-point-item"><span class="point-marker">‚úì</span><p><strong>Cromoglicate is given as a preventative drug.</strong></p></li>
                                <li class="key-point-item"><span class="point-marker">‚úì</span><p><strong>Inhaler technique is an important part of patient education.</strong></p></li>
                                <li class="key-point-item"><span class="point-marker">‚úì</span><p><strong>COPD is a general term which includes the conditions chronic bronchitis and emphysema, the most common cause is smoking.</strong></p></li>
                                <li class="key-point-item"><span class="point-marker">‚úì</span><p><strong>Drugs that may be considered for COPD include beta-agonists, antimuscarinics and theophylline.</strong></p></li>
                            </ul>
                        </div>
                    </aside>

                    <!-- Calculations -->
                    <div class="content-card">
                        <h2 id="calculations">Calculations</h2>
                        <p><strong>Question:</strong> Your mentor asks you to check a dose of medication for IV injection. The patient requires aminophylline 50 mg and the ampoule comes as 250 mg in 10 ml. How much should have been drawn into the syringe?</p>
                        <p><em>(Answer can be found in the Calculations section of Chapter 10)</em></p>
                    </div>

                    <!-- Multiple Choice Questions -->
                    <div class="content-card">
                        <h2 id="multiple-choice-questions">Multiple choice questions</h2>
                        <ol class="enhanced-list">
                            <li class="list-item"><span class="list-marker"></span><span class="list-content">
                                <strong>1 Which of the following drugs is a beta 2 agonist used in the treatment of asthma?</strong><br>
                                a) Ipratropium<br>
                                b) Salbutamol<br>
                                c) Beclometasone<br>
                                d) Theophylline
                            </span></li>
                            <li class="list-item"><span class="list-marker"></span><span class="list-content">
                                <strong>2 What measures might be employed to help reduce the possibility of developing oral candidiasis when using inhaled corticosteroids?</strong><br>
                                a) Using a spacer and altering the inhaler technique<br>
                                b) Altering the inhaler technique and taking antifungal lozenges<br>
                                c) Rinsing the mouth and altering their inhaler technique<br>
                                d) Using a spacer and rinsing the mouth after taking the medication
                            </span></li>
                        </ol>
                    </div>

                    <!-- Recommended Reading -->
                    <div class="content-card">
                        <h2 id="recommended-further-reading">Recommended further reading</h2>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Campbell, D.A. (2006) Respiratory nursing: understanding difficult-to-control asthma, Nursing Times, 102(36): 44-5.</span></li>
                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Newell, K. and Hume, S. (2006) Choosing the right inhaler for patients with asthma, Nursing Standard, 21(5): 46-8.</span></li>
                            <li class="list-item"><span class="list-marker"></span><span class="list-content">NICE (National Institute for Clinical Excellence) (2004) Clinical Guideline 5: Chronic Obstructive Pulmonary Disease. London: NICE.</span></li>
                            <li class="list-item"><span class="list-marker"></span><span class="list-content">O'Connor, B. (2001) Inhaler devices: compliance with steroid therapy, Nursing Standard, 15(48): 40-2.</span></li>
                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Rees, J. and Kanabar, D. (2006) ABC of Asthma, 5th edn. Malden, MA: Blackwell.</span></li>
                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Roberts, J. and Williams, A. (2004) Quality-of-life and asthma control with low-dose inhaled corticosteroids, British Journal of Nursing, 13(19): 1124-9.</span></li>
                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Scullion, J. (2005) A proactive approach to asthma, Nursing Standard, 20(9): 57-66, 68.</span></li>
                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Wolfe, S. (2006) Respiratory nursing: treatment of allergic rhinitis and asthma, Nursing Times, 102(20): 49-52.</span></li>
                        </ul>
                    </div>

                </div>

                <!-- Bottom Navigation -->
                <nav class="document-nav document-nav--bottom" role="navigation" aria-label="Document navigation">
                    <div class="nav-container">
                        <a href="topic-07-anticoagulant.html" class="nav-button nav-button--prev nav-button--large">
                            <span class="nav-icon">‚Üê</span>
                            <div class="nav-content">
                                <span class="nav-label">Previous</span>
                                <span class="nav-title">Anticoagulant therapy</span>
                            </div>
                        </a>
                        
                        <a href="../index.html" class="nav-button nav-button--toc">
                            <span class="nav-icon">üìö</span>
                            <span class="nav-text">All Topics</span>
                        </a>
                        
                        <a href="topic-09-chronic-2.html" class="nav-button nav-button--next nav-button--large">
                            <div class="nav-content">
                                <span class="nav-label">Next</span>
                                <span class="nav-title">Drugs used in chronic conditions 2</span>
                            </div>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

<!-- Lightbox Modal -->
    <div class="lightbox-modal" id="lightbox-modal" role="dialog" aria-modal="true" aria-label="Image viewer" hidden>
        <div class="lightbox-backdrop"></div>
        <div class="lightbox-content">
            <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
            <img class="lightbox-image" src="" alt="">
            <p class="lightbox-caption"></p>
        </div>
    </div>

    <!-- Scripts -->
    <script src="../js/theme.js"></script>
    <script src="../js/progress.js"></script>
    <script src="../js/interactions.js"></script>
</body>
</html>
</body>
</html>